Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Junyun Lai

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Scientific Reports|September 1, 2017
TCR-like antibodies mediate complement and antibody-dependent cellular cytotoxicity against Epstein-Barr virus-transformed B lymphoblastoid cells expressing different HLA-A*02 microvariantsJunyun Lai, Joanna Ai Ling Choo, Wei Jian Tan, et al.
Cell Reports. Medicine|January 25, 2023
CD28-CAR-T cell activation through FYN kinase signaling rather than LCK enhances therapeutic performanceLing Wu, Joanna Brzostek, Previtha Dawn Sakthi Vale, et al.
Immunity|July 1, 2023
Single-cell protein expression profiling resolves circulating and resident memory T cell diversity across tissues and infection contextsMaximilien Evrard, Etienne Becht, Raissa Fonseca, et al.
Nature Communications|May 29, 2021
CRISPR/Cas9 mediated deletion of the adenosine A2A receptor enhances CAR T cell efficacyLauren Giuffrida, Kevin Sek, Melissa A Henderson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 23, 2019
Macrophage-Derived CXCL9 and CXCL10 Are Required for Antitumor Immune Responses Following Immune Checkpoint BlockadeImran G House, Peter Savas, Junyun Lai, et al.
Nature Immunology|May 20, 2020
Adoptive cellular therapy with T cells expressing the dendritic cell growth factor Flt3L drives epitope spreading and antitumor immunityJunyun Lai, Sherly Mardiana, Imran G House, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 1, 2020
IL-15 Preconditioning Augments CAR T Cell Responses to Checkpoint Blockade for Improved Treatment of Solid TumorsLauren Giuffrida, Kevin Sek, Melissa A Henderson, et al.
Cancer Cell|September 30, 2022
Inhibition of the CtBP complex and FBXO11 enhances MHC class II expression and anti-cancer immune responsesKah Lok Chan, Juliana Gomez, Chelisa Cardinez, et al.
Nature Communications|November 2, 2023
A<sub>2A</sub>R eGFP reporter mouse enables elucidation of A<sub>2A</sub>R expression dynamics during anti-tumor immune responsesKirsten L Todd, Junyun Lai, Kevin Sek, et al.
Cell Reports|August 22, 2023
CRISPR-Cas9 screening identifies an IRF1-SOCS1-mediated negative feedback loop that limits CXCL9 expression and antitumor immunityImran G House, Emily B Derrick, Kevin Sek, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Scientific Reports|September 1, 2017
TCR-like antibodies mediate complement and antibody-dependent cellular cytotoxicity against Epstein-Barr virus-transformed B lymphoblastoid cells expressing different HLA-A*02 microvariantsJunyun Lai, Joanna Ai Ling Choo, Wei Jian Tan, et al.
Cell Reports. Medicine|January 25, 2023
CD28-CAR-T cell activation through FYN kinase signaling rather than LCK enhances therapeutic performanceLing Wu, Joanna Brzostek, Previtha Dawn Sakthi Vale, et al.
Immunity|July 1, 2023
Single-cell protein expression profiling resolves circulating and resident memory T cell diversity across tissues and infection contextsMaximilien Evrard, Etienne Becht, Raissa Fonseca, et al.
Nature Communications|May 29, 2021
CRISPR/Cas9 mediated deletion of the adenosine A2A receptor enhances CAR T cell efficacyLauren Giuffrida, Kevin Sek, Melissa A Henderson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 23, 2019
Macrophage-Derived CXCL9 and CXCL10 Are Required for Antitumor Immune Responses Following Immune Checkpoint BlockadeImran G House, Peter Savas, Junyun Lai, et al.
Nature Immunology|May 20, 2020
Adoptive cellular therapy with T cells expressing the dendritic cell growth factor Flt3L drives epitope spreading and antitumor immunityJunyun Lai, Sherly Mardiana, Imran G House, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 1, 2020
IL-15 Preconditioning Augments CAR T Cell Responses to Checkpoint Blockade for Improved Treatment of Solid TumorsLauren Giuffrida, Kevin Sek, Melissa A Henderson, et al.
Cancer Cell|September 30, 2022
Inhibition of the CtBP complex and FBXO11 enhances MHC class II expression and anti-cancer immune responsesKah Lok Chan, Juliana Gomez, Chelisa Cardinez, et al.
Nature Communications|November 2, 2023
A<sub>2A</sub>R eGFP reporter mouse enables elucidation of A<sub>2A</sub>R expression dynamics during anti-tumor immune responsesKirsten L Todd, Junyun Lai, Kevin Sek, et al.
Cell Reports|August 22, 2023
CRISPR-Cas9 screening identifies an IRF1-SOCS1-mediated negative feedback loop that limits CXCL9 expression and antitumor immunityImran G House, Emily B Derrick, Kevin Sek, et al.
Pageof 3